Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK

Nicolas Roche, Hicham Benhaddi, Marianka van der Tol, Jonathan Chambers, Job FM van Boven, Leif Bjermer, Marc miravitlles, David Price, Jaco Voorham
European Respiratory Journal 2017 50: PA937; DOI: 10.1183/1393003.congress-2017.PA937

Article Information

vol. 50 no. suppl 61
DOI 
https://doi.org/10.1183/1393003.congress-2017.PA937
Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online December 6, 2017.
Copyright & Usage 
Copyright ©the authors 2017

Author Information

  1. Nicolas Roche1,
  2. Hicham Benhaddi2,
  3. Marianka van der Tol3,
  4. Jonathan Chambers4,
  5. Job FM van Boven5,
  6. Leif Bjermer6,
  7. Marc miravitlles7,
  8. David Price8 and
  9. Jaco Voorham8
  1. 1Hôpitaux Universitaires Paris Centre, Paris, France
  2. 2Teva Pharmaceuticals Europe B.V., Brussels, Belgium
  3. 3Teva Pharmaceuticals Europe B.V., Amsterdam, Netherlands
  4. 4Teva Pharmaceuticals Europe B.V., Winchester, United Kingdom
  5. 5Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  6. 6Skane University Hospital, Lund, Sweden
  7. 7Hospital Universitari Vall d'Hebron, Barcelona, Spain
  8. 8Observational and Pragmatic Research Institute, Singapore, Singapore

Article usage

Article usage: December 2017 to August 2023

AbstractFullPdf
Dec 20171800
Jan 20184300
Feb 20182300
Mar 20183600
Apr 20183700
May 20183300
Jun 20184800
Jul 20184600
Aug 20186100
Sep 20187100
Oct 20186900
Nov 20186500
Dec 20184900
Jan 20196000
Feb 20197100
Mar 20197200
Apr 20196500
May 201918300
Jun 20197200
Jul 20198000
Aug 20197000
Sep 20195800
Oct 20193900
Nov 20195000
Dec 20193800
Jan 20204700
Feb 20203400
Mar 20209100
Apr 20208500
May 20204800
Jun 20203800
Jul 20203800
Aug 20203900
Sep 20205400
Oct 20205200
Nov 20206500
Dec 20203800
Jan 20215600
Feb 20215400
Mar 20214600
Apr 20213800
May 20214400
Jun 20214000
Jul 20213800
Aug 20212800
Sep 20213300
Oct 20214100
Nov 20213700
Dec 20214900
Jan 20225800
Feb 20222600
Mar 20222600
Apr 20223100
May 20223600
Jun 20223300
Jul 20227800
Aug 20224900
Sep 20227000
Oct 20223700
Nov 20226000
Dec 20223700
Jan 20233700
Feb 20234600
Mar 20235400
Apr 20233100
May 20236700
Jun 20236800
Jul 20236300
Aug 20237300

Altmetrics

Back to top
Email
Citation Tools

Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK
Nicolas Roche, Hicham Benhaddi, Marianka van der Tol, Jonathan Chambers, Job FM van Boven, Leif Bjermer, Marc miravitlles, David Price, Jaco Voorham
European Respiratory Journal Sep 2017, 50 (suppl 61) PA937; DOI: 10.1183/1393003.congress-2017.PA937
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To